# Ipamorelin: What It Is **By TelosRX Editorial Team** ยท 2026-09-21 **Ipamorelin is a synthetic peptide studied as a growth hormone secretagogue, and telos rx does not currently offer it for compounding. Here is what the molecule actually is, in plain terms, and where things stand if you were hoping to start it today.** What to know Ipamorelin is not currently offered by telos rx for compounding. It remains under review, not approved, with no confirmed date for any change. Telos rx currently offers BPC-157, PT-141, NAD+ nasal spray, and sermorelin for patients who want to start a compounded peptide protocol today. ## Ipamorelin, defined simply Ipamorelin is a small synthetic peptide made of five amino acids. It belongs to a class of compounds called growth hormone secretagogues, which are molecules studied for their ability to prompt the pituitary gland to release more of the body's own growth hormone. It is chemically distinct from growth hormone itself. Ipamorelin does not supply growth hormone directly. Instead, researchers describe it as working upstream, nudging a natural release pathway rather than replacing a hormone with an external dose. Ipamorelin is often grouped with other growth hormone-releasing peptides such as sermorelin and CJC-1295, and people researching one of these compounds frequently come across the others in the same search. They are related in category but are not identical molecules, and each has its own specific study history. ## Where ipamorelin came from and how it is discussed Ipamorelin was first described in the scientific literature decades ago. Researchers were looking for a way to trigger growth hormone release with more precision, without also stimulating unrelated hormones like cortisol. That narrower focus is one of the more frequently cited properties in early research on the compound. In practice, ipamorelin shows up today mostly in two contexts. One is laboratory and early clinical research, published in peer-reviewed journals and indexed on [databases such as PubMed Central](https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/). The other is the compounding pharmacy and wellness-clinic market, where interest has grown well ahead of any large-scale, definitive human trials. That gap between early research interest and thin clinical evidence is common across growth hormone secretagogues. It is worth keeping in mind whenever a source describes ipamorelin's effects with more confidence than the underlying research actually supports. A careful reader should notice the difference between a laboratory finding and a proven, repeatable clinical outcome in people. **Key takeaway:** Ipamorelin is a growth hormone secretagogue studied for prompting the body's own hormone release, not a source of growth hormone itself, and it is not currently offered by telos rx. ## Is ipamorelin available at telos rx? No. Ipamorelin is not currently part of the telos rx compounding program. There is no intake for it, and it cannot be added to an existing plan. You can read more about telos rx's current status on [ipamorelin](https://www.telosrx.com/pages/cjc-ipamorelin). telos rx is reviewing ipamorelin, along with a handful of other research peptides, for possible future inclusion in its program. That review is ongoing and carries no set timeline. A 2026 advisory committee made nonbinding recommendations touching on several research peptides, and that is a recommendation to regulators, not an approval that changes what any pharmacy can compound today. If a source implies ipamorelin is currently in stock, on the way, or newly cleared at telos rx, that description does not match where things actually stand. ## What ipamorelin is used for in research settings Published research on ipamorelin has mostly examined its effect on growth hormone levels in short-term studies. There is also early animal work on outcomes such as bone density. Human trials tend to be smaller and shorter than the trials that support long-established prescription hormone therapies, a point [recent review literature](https://pmc.ncbi.nlm.nih.gov/articles/PMC13322892/) on performance-related peptides has also raised. Interest from patients tends to center on general wellness goals, including sleep quality, recovery from exercise, and changes in body composition that people associate with growth hormone activity. None of those outcomes have been established with the kind of large, controlled trial evidence that exists for approved medications, and no compounded peptide should be marketed as if they had been. A licensed provider evaluating any growth hormone secretagogue weighs a thinner evidence base against a patient's individual history. That is one reason careful telehealth programs review these requests individually, rather than approving them automatically for anyone who submits a form. ## How it compares to related peptides People researching ipamorelin often also look into sermorelin and CJC-1295. All three are studied as ways to influence growth hormone release through related but distinct mechanisms. Sermorelin is currently offered by telos rx, while ipamorelin and CJC-1295 are not. It is common for someone who first hears about one of these peptides in a gym or online forum to assume the whole category works identically. That assumption skips over real differences in how each compound is studied, dosed, and regulated, differences a licensed provider can walk through individually. The distinction matters because "growth hormone secretagogue" is a category, not one specific compound. Each molecule in that category has its own dosing history, its own study base, and its own regulatory status, and treating them as interchangeable oversimplifies a genuinely nuanced area of peptide research. If your interest in ipamorelin is really an interest in supporting the body's own growth hormone signaling in general, it is worth asking a different question. A provider can tell you whether an available option like sermorelin addresses that same underlying goal, which is more productive than trying to source ipamorelin from an unreviewed seller. ## What "not currently offered" actually means It helps to be precise about what telos rx not offering ipamorelin does and does not mean. It does not mean the peptide has been rejected as unsafe, and it does not mean it will never be offered. It means the program has not added it, and no timeline exists for that decision. Some patients assume a peptide missing from a telehealth catalog must be illegal outright. That is usually not accurate. Compounding law works substance by substance, and a peptide can be legally compoundable in principle while a specific program still declines to offer it, whether for sourcing, quality, or clinical-review reasons. Other patients assume the opposite, that anything discussed in wellness circles must already be available somewhere legitimate if you look hard enough. That assumption is how people end up buying unregulated products online instead of getting an individualized review from a licensed provider. The honest middle ground is this. Ipamorelin is a real peptide with a real research history. It is not currently part of the telos rx program, and the reasons are about program status and regulatory clarity, not a verdict on the molecule itself. ## Which is right for you today If ipamorelin specifically brought you here, telos rx cannot offer it right now, and there is no confirmed date for that to change. If you are looking to start a compounded peptide protocol today, telos rx currently offers [BPC-157](https://www.telosrx.com/pages/bpc-157), [PT-141](https://www.telosrx.com/pages/pt-141), [NAD+ nasal spray](https://www.telosrx.com/pages/nad-nasal-spray), and [sermorelin](https://www.telosrx.com/pages/sermorelin). Sermorelin is the closest available option to what many people are actually looking for when they search for ipamorelin, since both are studied as growth hormone secretagogues. [Start an intake](https://start.telosrx.com/start-online-visit/peptides) if you want a licensed provider to walk you through whether sermorelin fits your goals. ## What a provider actually weighs during review When telos rx reviews any peptide for possible inclusion, the questions are practical rather than theoretical. Is there a reliable, quality-controlled source through a partner compounding pharmacy? Is the regulatory picture stable enough that patients will not be left mid-protocol if rules shift? Is there enough of a clinical basis for a provider to make sound, individualized decisions rather than approving everyone who asks? Those same questions apply to ipamorelin as they would to any peptide under consideration. Until they are answered to the program's satisfaction, offering the peptide would mean asking patients to accept more uncertainty than telos rx considers appropriate for a compounded medication. ## Frequently Asked Questions ### What exactly is ipamorelin? Ipamorelin is a synthetic five-amino-acid peptide studied as a growth hormone secretagogue. It is researched for its ability to prompt the pituitary gland to release the body's own growth hormone rather than supplying growth hormone directly. ### Does telos rx sell ipamorelin? No. Ipamorelin is not currently part of the telos rx compounding program. It is under internal review with no confirmed date for when, or whether, that will change. ### Is ipamorelin the same as growth hormone? No. Ipamorelin does not contain growth hormone. It is studied for its effect on the body's own release pathway, which is a distinct mechanism from directly administering growth hormone. ### How is ipamorelin different from sermorelin? Both are studied as growth hormone secretagogues, but they are chemically distinct peptides with separate research histories. Sermorelin is currently available through telos rx, while ipamorelin is not. ### Why hasn't telos rx added ipamorelin yet? telos rx is still reviewing ipamorelin for its compounding program. A 2026 advisory committee issued nonbinding recommendations on several research peptides, but that is guidance to regulators, not a regulatory approval or a program decision. ### What should I do if I am interested in ipamorelin? You can read about its current status on the telos rx ipamorelin page and consider whether sermorelin, which is currently available, addresses the same underlying goal. A provider can discuss the differences with you during an intake. _telos rx is LegitScript-certified. Compounded medications broadly are not FDA-approved, and ipamorelin is additionally not currently offered by telos rx. This article is general information, not medical advice, and does not replace guidance from your own provider._ Want to see the peptides telos rx offers today? [Read about sermorelin](https://www.telosrx.com/pages/sermorelin). --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/ipamorelin-what-it-is)